Premium Company Profile: GTx, Inc.

Publication Date	November 2007
Publisher	Datamonitor
Product Type	Report
Pages	54
ISBN Number	not applicable
Product Code	DAT08663

Price

£265.00
approximately: $495 | €336

PDF

PRINT £315 ($589 | €400)

Order above formats by FAX

Summary

GTx's main focus is to discover, develop and commercialize therapeutics for cancer and serious conditions related to men's health. The company has only one marketed product, Fareston, for the metastatic breast cancer indication.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

GTx is focused on the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle wasting and other serious medical conditions.

GTx derives its revenues from production and marketing of its own pharmaceutical products and from collaborative agreements consisting primarily of up-front payments and license fees to develop and commercialize its products with other pharmaceutical companies in the US and other countries.

GTx's biggest contributor to sales growth out to 2010 will be the sales of Acapodene. Revenues from Acapodene are expected to increase from $79 million in 2009 to $204 million in 2010.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Table Of Contents
- Overview
- Catalyst
- Summary
- Company Structure
- Company Overview And Key Facts
- Landmark Products And Services
- History
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Products & Services
- Marketed Products
- Pipeline Products
- Historical Product Sales
- Ac Forecast Product Sales
- Competitors And Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- Swot Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery And Product Development
- Sales
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
List Of Key Employees
- Key Employee Biographies
- Financial And Operational Overview
- Financial And Operational Overview
Appendix
- Ask The Analyst
- Datamonitor Consulting
- Disclaimer
Table Of Figures
- Figure 1: Gtx - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Figure 2: Gtx - Key Strategic Revenues, 2002-2006 ($ Mn)
- Figure 3: Gtx - Key Strategic Revenues, 2006-2010 ($ Mn)
Table Of Tables
- Table 1: Gtx - Key Facts
- Table 2: Gtx - Year-End Share Price And Market Capitalization, 2002-2006 ($)
- Table 3: Gtx - Key Events Impacting Share Price Performance
- Table 4: Gtx - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 5: Gtx - Operating Cost Ratio Analysis, 2002-2006 (% Of Total Revenues)
- Table 6: Gtx - Balance Sheet, 2002-2006 ($ Mn)
- Table 7: Gtx - Cash Flow, 2002-2006 ($ Mn)
- Table 8: Gtx - Revenue Breakdown, 2002-2006 ($ Mn)
- Table 9: Gtx - Marketed Products
- Table 10: Gtx - In-House Pipeline Products
- Table 11: Gtx - Collaboration Pipeline Products
- Table 12: Gtx - Historical Product Sales, 2002-2006 ($ Mn)
- Table 13: Gtx - Key Strategic Revenues, 2006-2010 ($ Mn)
- Table 14: Gtx - Key Competitors
- Table 15: Gtx - Key Suppliers
- Table 16: Gtx - Key Clients
- Table 17: Gtx - Key Shareholders
- Table 18: Gtx - Swot Analysis Summary
- Table 19: Gtx - Value Chain Analysis
- Table 20: Gtx - Scorecard
- Table 21: Gtx - Key Employees
- Table 22: Gtx - Financial And Operational Overview